User menu

Activity of chemotherapy in the palliative treatment of salivary gland tumors : review of the literature

Bibliographic reference RIZK, Sophia ; Robert, Annie ; Vandenhooft, Annick ; Airoldi, Mario ; Kornek, Gabriela ; et. al. Activity of chemotherapy in the palliative treatment of salivary gland tumors : review of the literature. In: European Archives of Oto-Rhino-Laryngology, Vol. 264, no. 6, p. 587-594 (2007)
Permanent URL http://hdl.handle.net/2078.1/10921
  1. Agulnik M, Siu LL (2004) An update on the systemic therapy of malignant salivary gland cancers: the role of chemotherapy and molecular targeted agents. Curr Med Chem Anti-Cancer Agents 4:543–551
  2. Airoldi M, Brando V, Giodano C, Gabriele P, Bussi M, Cortesina G (1994) Chemotherapy for recurrent salivary gland malignancies: experience of the ENT department of Turin University. ORL 56:105–111
  3. Airoldi M, Pedani F, Brando V, Gabriele P, Giordano C (1989) Cisplatin, epirubicin and 5-fluorouacil combination chemotherapy for recurrent carcinoma of salivary gland. Tumori 75:252–256
  4. Airoldi M, Fornari G, Pedani F, Marchionatti S, Gabriele AM, Succo G, Rosti G, Bumma C (2000) Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res 20:3781–3784
  5. Airoldi M, Pedani F, Succo G, Gabriele AM, Succo G, Rosti G, Bumma C (2001) Phase II randomized trial comparing vinorelbine versus vinorelbine plus ciplatin in patients with recurrent salivary gland malignancies. Cancer 91:541–547
  6. Alberts DS, Manning MR, Coulthard SW, Koopmann CF, Herman TS (1981) Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland. Cancer 47:645–648
  7. Belani CP, Eisenberger MA, Gray WC (1988) Preliminary experience with chemotherapy in advanced salivary gland neoplasms. Med Pediatr Oncol 16:197–202
  8. Creagan ET, Woods JE, Schutt AJ, O’Fallon JR (1983) Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of advanced non-squamous cell head and neck cancer. Cancer 52:2007–2010
  9. Dimery IW, Legha SS, Shirinian M, Hong WK (1990) Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma. J Clin Oncol 8:1056–1062
  10. Dreyfuss AI, Clark JR, Fallon BG, PosnerMR, Norris CM Jr, Miller D (1987) Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer 60:2869–2872
  11. Faivre S, Raymond E, Casiraghi O, Temam S, Berthaud P (2005) Imatinib mesylate can induce objective response in progressing, highly expressing KIT adenoid cystic carcinoma of the salivary gland. J Clin Oncol 23:6271–6273
  12. Fu KK, Leibel SA, Levine ML, Friedlander LM, Boles R, Phillips TL (1977) Carcinoma of the major and minor salivary glands. Analysis of treatment results and sites and causes of failure. Cancer 40:2882–2890
  13. Gedlicka C, Schüll B, Formamek M, Kornfehl J, Burian M, Knerer B, Selzer E, Scheihauer W, Kornek GV (2002) Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignancies. Anticancer Drugs 13:491–495
  14. Hill ME, Constenla DO, A’Hern RP, Henk JM, Rhys-Evans P, Breach N, Archer D, Gore ME (1997) Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma. Oral Oncol 33:275–278
  15. Jones AS, Phillips DE, Cook JA, Helliwell TR, A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands, 10.1038/bjc.1993.19
  16. Kaplan Michael J., Johns Michael E., Cantrell Robert W., Chemotherapy for Salivary Gland Cancer, 10.1177/019459988609500206
  17. Licitra L, Marchini S, Spinazzè S, Rossi A, Rocca A, Grandi C, Molinari R (1991) Cisplatin in advanced salivary gland tumor. Cancer 68:874–878
  18. Licitra L., Cavina R., Grandi C., Pahna S. D., Guzzo M., Demicheli R., Molinari R., Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma: A phase H trial of 22 patients, 10.1093/oxfordjournals.annonc.a010684
  19. Lim JJ, Kang S, Lee MR, Pai HK, Yoon HJ, Lee JI, Hong SP, Lim CY (2003) Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 32(9):552–561
  20. Mattox DE, Von Hoff DD, Balcerzak SP (1990) Southwest Oncology Group study of mitoxantrone for treatment of patients with advanced adenoid cystic carcinoma of the head and neck. Invest New Drugs 8:105–107
  21. Posner MR, Ervin TJ, Weichselbaum RR, Fabian RL, Miller D (1982) Chemotherapy of advanced salivary gland neoplasms. Cancer 50:2261–2264
  22. Regezi J, Batsakis J (1977) Histogenesis of salivary neoplasms. Otolaryngol Clin North Am 10:297–307
  23. Rentschler R, Burgess MA, Byers R (1977) Chemotherapy of malignant tumor major salivary gland neoplasms. A 25 year review of M.D. Anderson Hospital Experience. Cancer 40:619–624
  24. Schramm V. L., Srodes C., Myers E. N., Cisplatin Therapy for Adenoid Cystic Carcinoma, 10.1001/archotol.1981.00790480015004
  25. Suen JY, Johns ME (1980) Chemotherapy for salivary gland cancer. Laryngoscope 46:452–454
  26. Tannock IF, Sutherland DJ (1980) Chemotherapy for adenoid cystic carcinoma. Cancer 46:452–454
  27. Triozzi PL, Brantley A, Fisher S, Cole TB, Crocker I, Huang AT (1987) 5-Fluorouracil, cyclophosphamide, and vincristine for adenoid cystic carcinoma of the head and neck. Cancer 59:887–890
  28. Venook AP, Tseng A, Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD (1987) Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. J Clin Oncol 5:951–955
  29. Vermorken J. B., ten Bokkel Huinink W. W., Eisenhauer E. A., Favalli G., Belpomme D., Conte P. F., Kaye S. B., Carboplatin versus cisplatin, 10.1093/annonc/4.suppl_4.s41